176 related articles for article (PubMed ID: 20560296)
21. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
[TBL] [Abstract][Full Text] [Related]
22. IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis.
Nakanishi Y; Horimasu Y; Yamaguchi K; Sakamoto S; Masuda T; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
PLoS One; 2021; 16(6):e0252594. PubMed ID: 34086758
[TBL] [Abstract][Full Text] [Related]
23. [Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].
Peng SC; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):260-3. PubMed ID: 18846961
[TBL] [Abstract][Full Text] [Related]
24. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.
Shinoda H; Tasaka S; Fujishima S; Yamasawa W; Miyamoto K; Nakano Y; Kamata H; Hasegawa N; Ishizaka A
Respiration; 2009; 78(3):285-92. PubMed ID: 19270434
[TBL] [Abstract][Full Text] [Related]
25. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.
Huang H; Peng X; Nakajima J
Biosci Trends; 2013 Aug; 7(4):172-7. PubMed ID: 24056167
[TBL] [Abstract][Full Text] [Related]
26. Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Wang K; Ju Q; Cao J; Tang W; Zhang J
Medicine (Baltimore); 2017 Jun; 96(23):e7083. PubMed ID: 28591049
[TBL] [Abstract][Full Text] [Related]
27. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.
Noah TL; Murphy PC; Alink JJ; Leigh MW; Hull WM; Stahlman MT; Whitsett JA
Am J Respir Crit Care Med; 2003 Sep; 168(6):685-91. PubMed ID: 12829455
[TBL] [Abstract][Full Text] [Related]
28. Surfactant protein deficiency in familial interstitial lung disease.
Amin RS; Wert SE; Baughman RP; Tomashefski JF; Nogee LM; Brody AS; Hull WM; Whitsett JA
J Pediatr; 2001 Jul; 139(1):85-92. PubMed ID: 11445799
[TBL] [Abstract][Full Text] [Related]
29. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis.
Kucejko W; Chyczewska E; Naumnik W; Ossolińska M
Folia Histochem Cytobiol; 2009; 47(2):225-30. PubMed ID: 19995708
[TBL] [Abstract][Full Text] [Related]
30. Predicting prognosis in idiopathic pulmonary fibrosis.
Barlo NP; van Moorsel CH; van den Bosch JM; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(2):85-95. PubMed ID: 21319590
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
[TBL] [Abstract][Full Text] [Related]
32. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid.
Betsuyaku T; Kuroki Y; Nagai K; Nasuhara Y; Nishimura M
Eur Respir J; 2004 Dec; 24(6):964-70. PubMed ID: 15572540
[TBL] [Abstract][Full Text] [Related]
33. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D.
Takahashi H; Shiratori M; Kanai A; Chiba H; Kuroki Y; Abe S
Respirology; 2006 Jan; 11 Suppl():S51-4. PubMed ID: 16423272
[TBL] [Abstract][Full Text] [Related]
34. Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review.
Chiba H; Otsuka M; Takahashi H
Respir Investig; 2018 Sep; 56(5):384-391. PubMed ID: 30030108
[TBL] [Abstract][Full Text] [Related]
35. AIDS patients have increased surfactant protein D but normal mannose binding lectin levels in lung fluid.
Jambo KC; French N; Zijlstra E; Gordon SB
Respir Res; 2007 Jun; 8(1):42. PubMed ID: 17567900
[TBL] [Abstract][Full Text] [Related]
36. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.
Prasse A; Probst C; Bargagli E; Zissel G; Toews GB; Flaherty KR; Olschewski M; Rottoli P; Müller-Quernheim J
Am J Respir Crit Care Med; 2009 Apr; 179(8):717-23. PubMed ID: 19179488
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen predicts waitlist mortality in lung transplant candidates with idiopathic pulmonary fibrosis.
Yu WS; Lee JG; Paik HC; Kim SJ; Lee S; Kim SY; Park MS; Haam S
Eur J Cardiothorac Surg; 2018 Nov; 54(5):847-852. PubMed ID: 29672761
[TBL] [Abstract][Full Text] [Related]
38. Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
Kamio K; Usuki J; Azuma A; Matsuda K; Ishii T; Inomata M; Hayashi H; Kokuho N; Fujita K; Saito Y; Miya T; Gemma A
Pulm Pharmacol Ther; 2015 Jun; 32():29-36. PubMed ID: 25843005
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of serum hyaluronan in chronic fibrotic interstitial pneumonia.
Inokoshi Y; Tanino Y; Wang X; Sato S; Fukuhara N; Nikaido T; Fukuhara A; Saito J; Frevert CW; Munakata M
Respirology; 2013 Nov; 18(8):1236-43. PubMed ID: 23795990
[TBL] [Abstract][Full Text] [Related]
40. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
Alhamad EH; Masood M; Shaik SA; Arafah M
Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
